Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009.
BACKGROUND:<br>New emerging infections have no known treatment. Assessing potential drugs for safety and efficacy enables clinicians to make evidence-based treatment decisions and contributes to overall outbreak control. However, it is difficult to launch clinical trials in the unpredictable e...
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BioMed Central
2020
|